New Lab-Made blood vessel tested in heart bypass patients

NCT ID NCT06434935

ENROLLING_BY_INVITATION Disease control Sponsor: Vascudyne, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study tests the safety of a new synthetic tube (Vascudyne CAB A) used to reroute blood around blocked heart arteries. Five adults needing bypass surgery will receive this graft alongside standard grafts. Doctors will check if the graft stays open without problems for up to one year.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sanatario Italiano

    Asunción, Paraguay

More trials for these conditions

Other studies related to the condition(s) this trial covers.